Close Menu

NEW YORK – Transplant diagnostics company CareDx reported on Wednesday after the close of the market that its preliminary revenues for the first quarter of 2020 are expected to rise 47 percent year over year, despite a recent lag in testing service volumes due to the COVID-19 pandemic.

The company also withdrew its previously announced revenue guidance for full-year 2020 because of uncertainties surrounding the impact of COVID-19. Management will provide additional information during its Q1 earnings conference call.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An Associated Press report says China refrained from releasing the SARS-CoV-2 genome for more than a week in January, frustrating the World Health Organization.

The Lancet and the New England Journal of Medicine have issued expressions of concern regarding the data used in two COVID-19 papers, the New York Times reports. 

Researchers have sequenced the genome of the mayfly, garnering insight into how insects evolved wings, Science reports.

In Genome Research this week: gene expression in primate brain regions, inversions and breakpoint inverted repeats in the human genome, and more.